Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23880820 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: PEP02

Indicates status has not been verified in more than two years